Site icon Wide News Hub

COVID-19 vaccines | Covaxin vs Covishield vs Sputnik V

Equitable access to safe and effective vaccines is critical to ending the COVID-19 pandemic, so it is hugely encouraging to see so many vaccines proving and going into development.


Developed by Oxford University and UK-based AstraZeneca will be called Covishield in India

The interval between 1st and 2nd doses is 12-16 weeks

Efficacy after the second dose can vary from 70-90%

People above 18 years of age can opt for this vaccine

Covishield is less expensive. SII is selling this vaccine at INR 300 (government) and INR 600 (private centres)

Covishield is more easily available


Contact for Website development: WP Theme Developers

Indian vaccine produced by Bharat Biotech

The interval between the 2 doses is 4-6 weeks

This vaccine can be 78-100% effective after the second dose

This vaccine can be injected into younger people as well (12 years and above)

Covaxin is more expensive and is being sold at INR 400 (government) and INR 1200 (private facilities)

Fewer hospitals and healthcare centres are stocking Covaxin

Sputnik V

Russian vaccine produced by Dr Reddy’s Laboratories

The interval between the 2 doses is 3-4 weeks

Sputnik V Covid-19 vaccine showed a 97.6% efficacy

This vaccine can be injected into 18-60 years people’s

The imported vaccine has been priced at Rs 948 per dose.

As of time of publishing, the vaccine is only available at Apollo Hospital in Hyderabad for Rs 1,250 per jab for those aged 45 and above.

Check related category Articles: Health

Contact for Website development WP Theme Developers

Exit mobile version